Found: 100
Select item for more details and to access through your institution.
Dickkopf-1 and Sclerostin Serum Levels in Patients with Systemic Mastocytosis.
- Published in:
- Calcified Tissue International, 2015, v. 96, n. 5, p. 410, doi. 10.1007/s00223-015-9969-5
- By:
- Publication type:
- Article
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01025-7
- By:
- Publication type:
- Article
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0815-5
- By:
- Publication type:
- Article
Hymenoptera Allergy and Mast Cell Activation Syndromes.
- Published in:
- Current Allergy & Asthma Reports, 2016, v. 16, n. 1, p. 1, doi. 10.1007/s11882-015-0582-5
- By:
- Publication type:
- Article
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.
- Published in:
- Current Allergy & Asthma Reports, 2015, v. 15, n. 8, p. 1, doi. 10.1007/s11882-015-0550-0
- By:
- Publication type:
- Article
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2298, doi. 10.3390/ijms21072298
- By:
- Publication type:
- Article
Systemic Mastocytosis: Multidisciplinary Approach.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.068
- By:
- Publication type:
- Article
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 637, doi. 10.1111/bjh.19104
- By:
- Publication type:
- Article
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 440, doi. 10.1111/bjh.18537
- By:
- Publication type:
- Article
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 190, doi. 10.1111/bjh.18057
- By:
- Publication type:
- Article
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 559, doi. 10.1111/bjh.17890
- By:
- Publication type:
- Article
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 845, doi. 10.1111/bjh.17405
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 271, doi. 10.1111/bjh.17301
- By:
- Publication type:
- Article
Philadelphia‐positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID‐19 pandemic: a Campus ALL study.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. e3, doi. 10.1111/bjh.16758
- By:
- Publication type:
- Article
A journey through infectious risk associated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 286, doi. 10.1111/bjh.16174
- By:
- Publication type:
- Article
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 35, doi. 10.1111/bjh.15497
- By:
- Publication type:
- Article
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 273, doi. 10.1186/1476-4598-9-273
- By:
- Publication type:
- Article
Prognostic impact of KMT2A‐AFF1‐positivity in 926 BCR‐ABL1‐negative B‐lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E334, doi. 10.1002/ajh.26253
- By:
- Publication type:
- Article
α-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL<sup>+</sup> Cells in Synergism with Imatinib and Nilotinib.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046674
- By:
- Publication type:
- Article
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034432
- By:
- Publication type:
- Article
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 437, doi. 10.1007/s00277-023-05577-9
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1099, doi. 10.1007/s00277-023-05162-0
- By:
- Publication type:
- Article
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
- By:
- Publication type:
- Article
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
- Published in:
- 2019
- By:
- Publication type:
- Letter
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
EUTOS score predicts early optimal response to imatinib according to the revised 2013 ELN recommendations.
- Published in:
- 2014
- By:
- Publication type:
- Letter
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00468-7
- By:
- Publication type:
- Article
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5027, doi. 10.3390/cancers15205027
- By:
- Publication type:
- Article
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4623, doi. 10.3390/cancers15184623
- By:
- Publication type:
- Article
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3706, doi. 10.3390/cancers15143706
- By:
- Publication type:
- Article
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6380, doi. 10.3390/cancers13246380
- By:
- Publication type:
- Article
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1311, doi. 10.3390/cancers13061311
- By:
- Publication type:
- Article
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2696, doi. 10.3390/cancers12092696
- By:
- Publication type:
- Article
Management of polycythemia vera: A survey of treatment patterns in Italy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889
- By:
- Publication type:
- Article
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 286, doi. 10.1111/ejh.13436
- By:
- Publication type:
- Article
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC".
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3180, doi. 10.1002/cam4.5158
- By:
- Publication type:
- Article
The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6310, doi. 10.1002/cam4.4179
- By:
- Publication type:
- Article
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1726, doi. 10.1002/cam4.3778
- By:
- Publication type:
- Article